Near-fatal pulmonary embolism

Mount Sinai Journal of Medicine

Volumn 68, Issue 6, 2001, Pages 370-377

  DePalo, L R ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Echocardiography; Pulmonary embolism; Thrombolytic therapy

Indexed keywords

FIBRINOLYTIC AGENT; HEPARIN; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE; WARFARIN;

AGED; ANTICOAGULATION; ARTICLE; BLOOD CLOT LYSIS; CASE REPORT; CRITICAL ILLNESS; DEEP VEIN THROMBOSIS; DIAGNOSTIC APPROACH ROUTE; EPIDEMIOLOGY; EVIDENCE BASED MEDICINE; FATALITY; FEMALE; HEPARINIZATION; HIP FRACTURE; HOSPITAL ADMISSION; HUMAN; LABORATORY TEST; LUNG EMBOLISM; ORTHOPEDIC SURGERY; PATIENT; RESPIRATORY DISTRESS; RESUSCITATION; RISK BENEFIT ANALYSIS; RISK FACTOR;

AGED; FATAL OUTCOME; FEMALE; HIP FRACTURES; HUMANS; PULMONARY EMBOLISM; VENOUS THROMBOSIS;

EID: 0034765707     PISSN: 00272507     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Venous thromboembolism: Risk factors and prophylaxis
2. Natural history of pulmonary embolism
3. Physician practices in the management of venous thromboembolism: A community-wide survey
4. Suspected deep vein thrombosis: Management by impedance plethysmography
5. Prevention of venous thromboembolism in general surgery patients: Results of a meta-analysis
6. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic and urologic surgery
7. Deep vein thrombosis and pulmonary embolism prophylaxis in the surgical patients
8. Survey of prophylaxis against venous thromboembolism in adults undergoing hip surgery
9. Venous stasis and deep vein thrombosis
10. Influence of anesthesia on blood flow to the calves during surgery
11. Operative venodilation: A previously unsuspected factor in the cause of post-operative deep vein thrombosis
12. Total hip replacement induces injury to remote veins in a canine model
13. Prophylaxis for deep venous thrombosis and pulmonary embolism
14. Prevention of venous thromboembolism
15. Prevention of venous thrombosis and pulmonary embolism in injured patients: A trial of anticoagulant prophylaxis with phenindione in middle-aged and elderly patients with fractured necks of femurs
16. Venous thromboembolic disease after hip surgery
17. Venous thromboembolism. Risk factors and prophylaxis
18. Value of the ventilation/perfusion scan in acute pulmonary embolism: Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED)
19. Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: Increasing the models utility with the SimpliRED-D-dimer
20. Diagnosis of pulmonary embolism with spiral CT: Comparison with pulmonary angiography and scintigraphy
21. Detection of pulmonary embolism in patients with unresolved clinical and scintigraphic diagnosis: Helical CT versus angiography
22. Acute pulmonary embolism: Assessment of helical CT for diagnosis
23. Echocardiographic evaluation of pulmonary embolism and its response to therapeutic interventions
24. Alteplase versus heparin in acute pulmonary embolism: Randomised trial assessing right-ventricular function and pulmonary perfusion
25. Prognostic significance of right ventricular hypokinesis and perfusion lung scan defects in pulmonary embolism
26. Antithrombotic therapy for venous thrombosis
27. Venous thromboembolism
28. Management of heparin therapy: Controlled prospective trial
29. Phase 1 results: Cooperative study
30. Phase 2 results
31. Effect of thrombolytic therapy on pulmonary-capillary blood volume in patients with pulmonary embolism
32. Recent advances in the diagnosis and lytic therapy of pulmonary embolism
33. Association between thrombolytic treatment and the prognosis of hemodynamically stable patients with major pulmonary embolism. Results of a multicenter registry
34. Streptokinase and heparin versus heparin alone in massive pulmonary embolism: A randomized controlled trial
35. PAIMS 2: Alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism
36. Thrombolytic therapy of acute pulmonary embolism: Current status and future potential
37. Risks for major bleeding from thrombolytic therapy in patients with acute pulmonary embolism. Consideration of noninvasive management